Citi downgrades Moderna to Sell, sets $80 price target
Tweet Send to a Friend
(Updated - September 30, 2026 5:03 AM EDT)
Citi analyst Geoff Meacham downgraded Moderna (NASDAQ: MRNA) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Geoff Meacham downgraded Moderna (NASDAQ: MRNA) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
